Literature DB >> 3772113

Serum-free in vitro bioassay for the detection of tumor necrosis factor.

S M Kramer, M E Carver.   

Abstract

A sensitive, reproducible in vitro bioassay is described for quantitating the cytolytic activity of tumor necrosis factor (TNF). The assay target cells, murine connective tissue L-M, are propagated and the assay performed under serum-free conditions. The quantitation of cytolytic activity is based on the ability of TNF to lyse L-M cells in the presence of actinomycin D, as measured by crystal violet dye uptake of residual viable cells. The assay is sensitive to 88 pg/ml TNF-alpha. The simplicity of the culture medium combined with high sensitivity and low variability make this a particularly well-suited bioassay for routine detection of TNF cytolytic activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772113     DOI: 10.1016/0022-1759(86)90189-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  26 in total

Review 1.  MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune diseases.

Authors:  C O Jacob; G D Lewis; H O McDevitt
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus.

Authors:  C O Jacob; Z Fronek; G D Lewis; M Koo; J A Hansen; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Interleukin 1 beta and phorbol ester induce tumour necrosis factor alpha production in a hepatic cell line (HepG2).

Authors:  S Frede; J Fandrey; W Jelkmann
Journal:  Pflugers Arch       Date:  1996-04       Impact factor: 3.657

4.  Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.

Authors:  J S Patton; P M Peters; J McCabe; D Crase; S Hansen; A B Chen; D Liggitt
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

5.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

Authors:  C O Jacob; S Aiso; S A Michie; H O McDevitt; H Acha-Orbea
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

6.  Biological activity of mutants of human tumour necrosis factor-alpha.

Authors:  R Kircheis; J Milleck; V G Korobko; L N Shingarova; D Behnke; H E Schmidt
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

7.  Increased tumour necrosis factor alpha production by neutrophils in patients with hepatitis B.

Authors:  X Fan; Z Zhang
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

8.  The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats.

Authors:  M Sakr; G Zetti; C McClain; J Gavaler; M Nalesnik; S Todo; T Starzl; D Van Thiel
Journal:  Transplantation       Date:  1992-05       Impact factor: 4.939

9.  Weight loss in obese mice persistently infected with lymphocytic choriomeningitis virus is not associated with elevated tumor necrosis factor/cachectin activity in peritoneal macrophages.

Authors:  J L Lathey; M B Oldstone
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

10.  Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury.

Authors:  S E Goldblum; B Hennig; M Jay; K Yoneda; C J McClain
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.